"If" there was an offer of $6 billion now than obviously Dr. P sees the worth to shareholders (including himself) as much higher down the road as he crunches these numbers also. If his conclusion was that the dilution would make the company worth less down the road than he would have taken the $6 billion offer today.
I dont know why you continue to use those numbers but you do NOT include un-executed warrants or options in the O/S count.
#2 Where is all the money going from this supposed dilution you are referring to? If we hit 300million shares O/S. Thats an additional $200-$400 million dollars that would be raised. All 3 trials are estimated to cost $35 million.
Are you saying we may need to raise 10 times the money needed to complete all 3 trials to fund operating costs for a 3 man show???
#3 If we get acquired after FDA approval we can expect an offer much closer to $12-18 billion (2-3 times market share), not $6 billion.
#4 Lets say all of your assumptions were true. And we get purchased for $20 in 24 months. In what world is a 2000% roi in 2 years unattractive??? Or "much less attractive"???
News 
Market Data 
Discover 
AI
